22157.jpg
$2.68 Billion Direct-to-Consumer Genetic Testing Markets: Mitochondrial DNA Testing, Single Nucleotide Polymorphism Testing, and Y Chromosome Testing - Global Forecast to 2025
February 11, 2021 07:08 ET | Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Direct-to-Consumer Genetic Testing Market Research Report by Type (Mitochondrial DNA Testing, Single Nucleotide Polymorphism Testing, and Y Chromosome...
22157.jpg
Whole Genome And Exome Sequencing Markets, 2023 by Research, Clinical, Direct to Consumer, AgriBio & Tumor
January 25, 2021 05:28 ET | Research and Markets
Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Whole Genome And Exome Sequencing Markets - By Research, Clinical, Direct to Consumer, AgriBio & Tumor with Executive and Consultant Guides 2020 to...
22157.jpg
Worldwide Cell Analysis Industry to 2027 - Increasing Government and Private Funding is Driving Growth
January 13, 2021 10:03 ET | Research and Markets
Dublin, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The "Cell Analysis Global Market - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The cell analysis global market is...
22157.jpg
Global Molecular Cytogenetics Markets, 2020-2027: Critical Importance of Molecular Biology in Laboratory Processes - Cornerstone for Present & Future Growth
December 02, 2020 08:28 ET | Research and Markets
Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...
22157.jpg
Cell Therapy and Gene Therapy Markets, 2030
November 06, 2020 06:28 ET | Research and Markets
Dublin, Nov. 06, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy and Gene Therapy Markets" report has been added to ResearchAndMarkets.com's offering. The report examines developments in cell and gene...
22157.jpg
Whole Genome And Exome Sequencing Markets, 2023
October 07, 2020 02:04 ET | Research and Markets
Dublin, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The "Whole Genome And Exome Sequencing Markets - By Research, Clinical, Direct to Consumer, AgriBio & Tumor with Executive and Consultant Guides 2020 to...
®_Bionano_RGB.jpg
Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics
March 01, 2019 08:00 ET | Bionano Genomics
SAN DIEGO, March 01, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
®_Bionano_RGB.jpg
Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications
January 14, 2019 08:00 ET | Bionano Genomics
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables ultra-sensitive...
®_Bionano_RGB.jpg
UPDATE – GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China
October 19, 2018 20:51 ET | Bionano Genomics; GrandOmics Biosciences
SAN DIEGO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
®_Bionano_RGB.jpg
Bionano Genomics’ Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease
October 16, 2018 15:00 ET | Bionano Genomics
SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...